Sleep Disorder Therapeutics Market
1 Study Coverage
1.1 Sleep Disorder Therapeutics Revenue in Sleep Disorder Therapeutics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Sleep Disorder Therapeutics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Sleep Disorder Therapeutics Market Size for the Year 2017-2028
1.2.2 Global Sleep Disorder Therapeutics Market Size for the Year 2017-2028
1.3 Sleep Disorder Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Sleep Disorder Therapeutics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Sleep Disorder Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Sleep Disorder Therapeutics Market Dynamics
1.4.1 Sleep Disorder Therapeutics Industry Trends
1.4.2 Sleep Disorder Therapeutics Market Drivers
1.4.3 Sleep Disorder Therapeutics Market Challenges
1.4.4 Sleep Disorder Therapeutics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Sleep Disorder Therapeutics by Type
2.1 Sleep Disorder Therapeutics Market Segment by Type
2.1.1 Insomnia
2.1.2 Excessive Sleep
2.1.3 Disturbed Sleep
2.2 Global Sleep Disorder Therapeutics Market Size by Type (2017, 2022 & 2028)
2.3 Global Sleep Disorder Therapeutics Market Size by Type (2017-2028)
2.4 United States Sleep Disorder Therapeutics Market Size by Type (2017, 2022 & 2028)
2.5 United States Sleep Disorder Therapeutics Market Size by Type (2017-2028)
3 Sleep Disorder Therapeutics by Application
3.1 Sleep Disorder Therapeutics Market Segment by Application
3.1.1 Hospital Pharmacies
3.1.2 Online Pharmacies
3.1.3 Retail Pharmacies
3.2 Global Sleep Disorder Therapeutics Market Size by Application (2017, 2022 & 2028)
3.3 Global Sleep Disorder Therapeutics Market Size by Application (2017-2028)
3.4 United States Sleep Disorder Therapeutics Market Size by Application (2017, 2022 & 2028)
3.5 United States Sleep Disorder Therapeutics Market Size by Application (2017-2028)
4 Global Sleep Disorder Therapeutics Competitor Landscape by Company
4.1 Global Sleep Disorder Therapeutics Market Size by Company
4.1.1 Top Global Sleep Disorder Therapeutics Companies Ranked by Revenue (2021)
4.1.2 Global Sleep Disorder Therapeutics Revenue by Player (2017-2022)
4.2 Global Sleep Disorder Therapeutics Concentration Ratio (CR)
4.2.1 Sleep Disorder Therapeutics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Sleep Disorder Therapeutics in 2021
4.2.3 Global Sleep Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Sleep Disorder Therapeutics Headquarters, Revenue in Sleep Disorder Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Sleep Disorder Therapeutics Headquarters and Area Served
4.3.2 Global Sleep Disorder Therapeutics Companies Revenue in Sleep Disorder Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Sleep Disorder Therapeutics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Sleep Disorder Therapeutics Market Size by Company
4.5.1 Top Sleep Disorder Therapeutics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Sleep Disorder Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Sleep Disorder Therapeutics Market Size by Region
5.1 Global Sleep Disorder Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Sleep Disorder Therapeutics Market Size by Region (2017-2028)
5.2.1 Global Sleep Disorder Therapeutics Market Size by Region: 2017-2022
5.2.2 Global Sleep Disorder Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Sleep Disorder Therapeutics Market Size YoY Growth 2017-2028
6.1.2 North America Sleep Disorder Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Sleep Disorder Therapeutics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Sleep Disorder Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Sleep Disorder Therapeutics Market Size YoY Growth 2017-2028
6.3.2 Europe Sleep Disorder Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Sleep Disorder Therapeutics Market Size YoY Growth 2017-2028
6.4.2 Latin America Sleep Disorder Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Sleep Disorder Therapeutics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Sleep Disorder Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Company Details
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Sleep Disorder Therapeutics Introduction
7.1.4 Sanofi Revenue in Sleep Disorder Therapeutics Business (2017-2022)
7.1.5 Sanofi Recent Development
7.2 Sunovion Pharmaceuticals
7.2.1 Sunovion Pharmaceuticals Company Details
7.2.2 Sunovion Pharmaceuticals Business Overview
7.2.3 Sunovion Pharmaceuticals Sleep Disorder Therapeutics Introduction
7.2.4 Sunovion Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2017-2022)
7.2.5 Sunovion Pharmaceuticals Recent Development
7.3 Takeda Pharmaceutical
7.3.1 Takeda Pharmaceutical Company Details
7.3.2 Takeda Pharmaceutical Business Overview
7.3.3 Takeda Pharmaceutical Sleep Disorder Therapeutics Introduction
7.3.4 Takeda Pharmaceutical Revenue in Sleep Disorder Therapeutics Business (2017-2022)
7.3.5 Takeda Pharmaceutical Recent Development
7.4 Somaxon Pharmaceuticals
7.4.1 Somaxon Pharmaceuticals Company Details
7.4.2 Somaxon Pharmaceuticals Business Overview
7.4.3 Somaxon Pharmaceuticals Sleep Disorder Therapeutics Introduction
7.4.4 Somaxon Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2017-2022)
7.4.5 Somaxon Pharmaceuticals Recent Development
7.5 Vanda Pharmaceuticals
7.5.1 Vanda Pharmaceuticals Company Details
7.5.2 Vanda Pharmaceuticals Business Overview
7.5.3 Vanda Pharmaceuticals Sleep Disorder Therapeutics Introduction
7.5.4 Vanda Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2017-2022)
7.5.5 Vanda Pharmaceuticals Recent Development
7.6 Eli Lilly
7.6.1 Eli Lilly Company Details
7.6.2 Eli Lilly Business Overview
7.6.3 Eli Lilly Sleep Disorder Therapeutics Introduction
7.6.4 Eli Lilly Revenue in Sleep Disorder Therapeutics Business (2017-2022)
7.6.5 Eli Lilly Recent Development
7.7 GSK
7.7.1 GSK Company Details
7.7.2 GSK Business Overview
7.7.3 GSK Sleep Disorder Therapeutics Introduction
7.7.4 GSK Revenue in Sleep Disorder Therapeutics Business (2017-2022)
7.7.5 GSK Recent Development
7.8 Neurim Pharmaceuticals
7.8.1 Neurim Pharmaceuticals Company Details
7.8.2 Neurim Pharmaceuticals Business Overview
7.8.3 Neurim Pharmaceuticals Sleep Disorder Therapeutics Introduction
7.8.4 Neurim Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2017-2022)
7.8.5 Neurim Pharmaceuticals Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Sleep Disorder Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Sleep Disorder Therapeutics Market Trends
Table 3. Sleep Disorder Therapeutics Market Drivers
Table 4. Sleep Disorder Therapeutics Market Challenges
Table 5. Sleep Disorder Therapeutics Market Restraints
Table 6. Global Sleep Disorder Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Sleep Disorder Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Sleep Disorder Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Sleep Disorder Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Sleep Disorder Therapeutics Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Sleep Disorder Therapeutics Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Sleep Disorder Therapeutics Revenue Share by Player, 2017-2022
Table 13. Global Sleep Disorder Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sleep Disorder Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleep Disorder Therapeutics as of 2021)
Table 15. Top Players of Sleep Disorder Therapeutics in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Sleep Disorder Therapeutics Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Sleep Disorder Therapeutics Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Sleep Disorder Therapeutics Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Sleep Disorder Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Sleep Disorder Therapeutics Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Sleep Disorder Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Sleep Disorder Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Sleep Disorder Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Sleep Disorder Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Sleep Disorder Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Sleep Disorder Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Sleep Disorder Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Sleep Disorder Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Sanofi Company Details
Table 31. Sanofi Business Overview
Table 32. Sanofi Sleep Disorder Therapeutics Product
Table 33. Sanofi Revenue in Sleep Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 34. Sanofi Recent Development
Table 35. Sunovion Pharmaceuticals Company Details
Table 36. Sunovion Pharmaceuticals Business Overview
Table 37. Sunovion Pharmaceuticals Sleep Disorder Therapeutics Product
Table 38. Sunovion Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 39. Sunovion Pharmaceuticals Recent Development
Table 40. Takeda Pharmaceutical Company Details
Table 41. Takeda Pharmaceutical Business Overview
Table 42. Takeda Pharmaceutical Sleep Disorder Therapeutics Product
Table 43. Takeda Pharmaceutical Revenue in Sleep Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 44. Takeda Pharmaceutical Recent Development
Table 45. Somaxon Pharmaceuticals Company Details
Table 46. Somaxon Pharmaceuticals Business Overview
Table 47. Somaxon Pharmaceuticals Sleep Disorder Therapeutics Product
Table 48. Somaxon Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 49. Somaxon Pharmaceuticals Recent Development
Table 50. Vanda Pharmaceuticals Company Details
Table 51. Vanda Pharmaceuticals Business Overview
Table 52. Vanda Pharmaceuticals Sleep Disorder Therapeutics Product
Table 53. Vanda Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 54. Vanda Pharmaceuticals Recent Development
Table 55. Eli Lilly Company Details
Table 56. Eli Lilly Business Overview
Table 57. Eli Lilly Sleep Disorder Therapeutics Product
Table 58. Eli Lilly Revenue in Sleep Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 59. Eli Lilly Recent Development
Table 60. GSK Company Details
Table 61. GSK Business Overview
Table 62. GSK Sleep Disorder Therapeutics Product
Table 63. GSK Revenue in Sleep Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 64. GSK Recent Development
Table 65. Neurim Pharmaceuticals Company Details
Table 66. Neurim Pharmaceuticals Business Overview
Table 67. Neurim Pharmaceuticals Sleep Disorder Therapeutics Product
Table 68. Neurim Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 69. Neurim Pharmaceuticals Recent Development
Table 70. Research Programs/Design for This Report
Table 71. Key Data Information from Secondary Sources
Table 72. Key Data Information from Primary Sources
List of Figures
Figure 1. Sleep Disorder Therapeutics Product Picture
Figure 2. Global Sleep Disorder Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Sleep Disorder Therapeutics Market Size 2017-2028 (US$ Million)
Figure 4. United States Sleep Disorder Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Sleep Disorder Therapeutics Market Size 2017-2028 (US$ Million)
Figure 6. United States Sleep Disorder Therapeutics Market Share in Global 2017-2028
Figure 7. Sleep Disorder Therapeutics Report Years Considered
Figure 8. Product Picture of Insomnia
Figure 9. Product Picture of Excessive Sleep
Figure 10. Product Picture of Disturbed Sleep
Figure 11. Global Sleep Disorder Therapeutics Market Share by Type in 2022 & 2028
Figure 12. Global Sleep Disorder Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 13. Global Sleep Disorder Therapeutics Market Share by Type (2017-2028)
Figure 14. United States Sleep Disorder Therapeutics Market Share by Type in 2022 & 2028
Figure 15. United States Sleep Disorder Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 16. United States Sleep Disorder Therapeutics Market Share by Type (2017-2028)
Figure 17. Product Picture of Hospital Pharmacies
Figure 18. Product Picture of Online Pharmacies
Figure 19. Product Picture of Retail Pharmacies
Figure 20. Global Sleep Disorder Therapeutics Market Share by Application in 2022 & 2028
Figure 21. Global Sleep Disorder Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 22. Global Sleep Disorder Therapeutics Market Share by Application (2017-2028)
Figure 23. United States Sleep Disorder Therapeutics Market Share by Application in 2022 & 2028
Figure 24. United States Sleep Disorder Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 25. United States Sleep Disorder Therapeutics Market Share by Application (2017-2028)
Figure 26. North America Sleep Disorder Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 27. U.S. Sleep Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Canada Sleep Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Europe Sleep Disorder Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 30. Germany Sleep Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. France Sleep Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. U.K. Sleep Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Italy Sleep Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Russia Sleep Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Sleep Disorder Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 36. China Sleep Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Japan Sleep Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. South Korea Sleep Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. India Sleep Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Australia Sleep Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Taiwan Sleep Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Indonesia Sleep Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Thailand Sleep Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Malaysia Sleep Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Philippines Sleep Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Latin America Sleep Disorder Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 47. Mexico Sleep Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Brazil Sleep Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Argentina Sleep Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Sleep Disorder Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 51. Turkey Sleep Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Sleep Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. U.A.E Sleep Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Sanofi Revenue Growth Rate in Sleep Disorder Therapeutics Business (2017-2022)
Figure 55. Sunovion Pharmaceuticals Revenue Growth Rate in Sleep Disorder Therapeutics Business (2017-2022)
Figure 56. Takeda Pharmaceutical Revenue Growth Rate in Sleep Disorder Therapeutics Business (2017-2022)
Figure 57. Somaxon Pharmaceuticals Revenue Growth Rate in Sleep Disorder Therapeutics Business (2017-2022)
Figure 58. Vanda Pharmaceuticals Revenue Growth Rate in Sleep Disorder Therapeutics Business (2017-2022)
Figure 59. Eli Lilly Revenue Growth Rate in Sleep Disorder Therapeutics Business (2017-2022)
Figure 60. GSK Revenue Growth Rate in Sleep Disorder Therapeutics Business (2017-2022)
Figure 61. Neurim Pharmaceuticals Revenue Growth Rate in Sleep Disorder Therapeutics Business (2017-2022)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed